Improving Our Value by Improving Our Care

Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in deep specialty-pharmacy expertise, Diplomat’s innovative service model unites complementary brands to anticipate market needs, create shareholder value, and drive better patient outcomes. TEST

Date Filing Filing Description Download
August 26, 2019 SC 13G Statement of Ownership
August 9, 2019 10-Q Quarterly Report
August 9, 2019 8-K Current report filing

NYSE: DPLO

+0.06 +1.1% $ 5.52 Volume: 1,114,010 Common Stock | 20 minute delay September 20, 2019

Investor Contact

Terri Anne Powers,
Vice President, Investor Relations
Diplomat Pharmacy Inc.
tpowers@diplomat.is
Phone: 312.889.5244

Email Now